Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.96 USD | +1.64% | -0.80% | +28.50% |
Business Summary
Number of employees: 46
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Therapeutics
100.0
%
| 16 | 100.0 % | 20 | 100.0 % | +21.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 20 | 100.0 % | +21.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dan Hicklin
FOU | Founder | 61 | 17-10-18 |
Luke Evnin
FOU | Founder | 60 | 17-10-18 |
Timothy Trost
DFI | Director of Finance/CFO | 66 | 21-02-07 |
Chief Tech/Sci/R&D Officer | 65 | 21-06-14 | |
Randi Isaacs
CTO | Chief Tech/Sci/R&D Officer | 68 | 20-10-31 |
Ellen Lubman
IRC | Investor Relations Contact | 48 | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Evnin
FOU | Founder | 60 | 17-10-18 |
Dan Hicklin
FOU | Founder | 61 | 17-10-18 |
Michael Sherman
BRD | Director/Board Member | 58 | 21-05-26 |
Briggs Morrison
BRD | Director/Board Member | 65 | 19-10-31 |
Alon Lazarus
BRD | Director/Board Member | 49 | 19-07-31 |
Derek DiRocco
BRD | Director/Board Member | 43 | 20-11-30 |
Michael Atkins
BRD | Director/Board Member | 69 | Jan. 03 |
Meeta Chatterjee
BRD | Director/Board Member | 69 | 21-10-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,455,367 | 40,731,744 ( 93.73 %) | 0 | 93.73 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.50% | 216M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+40.01% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- HOWL Stock
- Company Werewolf Therapeutics, Inc.